| For: | Ren FY, Piao XX, Jin AL. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12(29): 4656-4659 [PMID: 16937435 DOI: 10.3748/wjg.v12.i29.4656] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i29/4656.htm |
| Number | Citing Articles |
| 1 |
Melody J. Cunningham. Update on Thalassemia: Clinical Care and Complications. Hematology/Oncology Clinics of North America 2010; 24(1) doi: 10.1016/j.hoc.2009.11.006
|
| 2 |
C. Pocha, E. Dieperink, K. A. McMaken, A. Knott, P. Thuras, S. B. Ho. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study. Alimentary Pharmacology & Therapeutics 2013; 38(3) doi: 10.1111/apt.12370
|
| 3 |
Yagil Barazani, Jonathan R. Hiatt, Myron J. Tong, Ronald W. Busuttil. Chronic Viral Hepatitis and Hepatocellular Carcinoma. World Journal of Surgery 2007; 31(6) doi: 10.1007/s00268-007-9041-3
|
| 4 |
Eo Rin Cho, Aesun Shin, Kui Son Choi, Hoo-Yeon Lee, Jeongseon Kim. Factors associated with use of ultrasonography screening for hepatocellular carcinoma among hepatitis B or C carriers. Cancer Epidemiology 2010; 34(6) doi: 10.1016/j.canep.2010.09.003
|
| 5 |
N. Wong, A. Haydon, W. Kemp, P. Wijeratne, S. Roberts. Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995–2009. Internal Medicine Journal 2013; 43(2) doi: 10.1111/j.1445-5994.2012.02755.x
|
| 6 |
N.A. Healy, H.M. Heneghan, N. Miller, C.K. Osborne, R. Schiff, M.J. Kerin. Systemic mirnas as potential biomarkers for malignancy. International Journal of Cancer 2012; 131(10) doi: 10.1002/ijc.27642
|
| 7 |
Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-on, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. World Journal of Gastroenterology 2016; 22(34): 7806-7812 doi: 10.3748/wjg.v22.i34.7806
|
| 8 |
Gek San Tan, Kiat Hon Lim, Hwee Tong Tan, May Lee Khoo, Sze Huey Tan, Han Chong Toh, Maxey Ching Ming Chung. Novel Proteomic Biomarker Panel for Prediction of Aggressive Metastatic Hepatocellular Carcinoma Relapse in Surgically Resectable Patients. Journal of Proteome Research 2014; 13(11) doi: 10.1021/pr500229n
|
| 9 |
Xue Qin, Liwen Lin, Zengnan Mo, Hui Lv, Yong Gao, Aihua Tan, Xiaobo Yang, Shan Li, Jinmin Zhao. Reference Intervals for Serum Alpha-Fetoprotein and Carcinoembryonic Antigen in Chinese Han Ethnic Males from the Fangchenggang Area Male Health and Examination Survey. The International Journal of Biological Markers 2011; 26(1) doi: 10.5301/JBM.2011.6364
|
| 10 |
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth C. Yanek, Robert A. Fisher. Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 2007; 84(10) doi: 10.1097/01.tp.0000287596.91520.1a
|
| 11 |
Dongfang Huang, Jianhuai Zhang, Jianbo Xu, Qiang Niu, Dinghua Zhou. Utility of Alpha-Fetoprotein and Ultrasound in the Diagnosis and Prognosis of Patients with Hepatocellular Liver Cancer. Journal of Multidisciplinary Healthcare 2024; doi: 10.2147/JMDH.S449276
|
| 12 |
Amit G. Singal, Benjamin Haaland, Neehar D. Parikh, A. Burak Ozbay, Carol Kirshner, Shubham Chakankar, Kyle Porter, Jagpreet Chhatwal, Turgay Ayer. Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis. Hepatology Communications 2022; 6(10) doi: 10.1002/hep4.2045
|
| 13 |
Tae Kyoung Kim, Kyoung Ho Lee, Korosh Khalili, Hyun-Jung Jang. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdominal Imaging 2011; 36(3) doi: 10.1007/s00261-011-9686-0
|
| 14 |
Lei Hu, Feng Xue, Yunyun Li, Minhua Shao, Yanfu Sun, Gongtian Wei. A Long-Term Follow-Up and Comprehensive Observation of Risk and Prognosis Factors of Recurrence and Survival After Resection of Hepatocellular Carcinoma. Cell Biochemistry and Biophysics 2014; 69(3) doi: 10.1007/s12013-013-9813-3
|
| 15 |
Jason C.H. Tsang, Y.M. Dennis Lo. Circulating nucleic acids in plasma/serum. Pathology 2007; 39(2) doi: 10.1080/00313020701230831
|
| 16 |
C. W. Strey, C. Zapletal, W. O. Bechstein. Chirurgische Therapie des hepatozellulären Karzinoms. Der Gastroenterologe 2007; 2(1) doi: 10.1007/s11377-006-0053-6
|
| 17 |
|
| 18 |
Melody J. Cunningham. Update on Thalassemia: Clinical Care and Complications. Pediatric Clinics of North America 2008; 55(2) doi: 10.1016/j.pcl.2008.02.002
|
| 19 |
Mary Qian YY, Rong Yuwei J, Peter Angus, Tony Schelleman, Lynne Johnson, Paul Gow. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Journal of Gastroenterology and Hepatology 2010; 25(5) doi: 10.1111/j.1440-1746.2009.06203.x
|
| 20 |
|
| 21 |
Francesco Izzo, Mauro Piccirillo, Vittorio Albino, Raffaele Palaia, Andrea Belli, Vincenza Granata, Sergio Setola, Roberta Fusco, Antonella Petrillo, Raffaele Orlando, Grazia Tosone, Fabrizio Scordino, Steven A. Curley. Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8900 high-risk patients. HPB 2013; 15(12) doi: 10.1111/hpb.12080
|
| 22 |
Garrett Richard Roll, John Paul Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; doi: 10.1016/B978-0-323-40232-3.00132-1
|